Selecting the primary endpoint in a randomized clinical trial: The ARE method

References

• Collett, D. (1994). Modelling Survival Data in Medical Research. London, UK: Chapman and Hall.
   Google Scholar
• Ferreira-González, I., Busse, J., Heels-Ansdell, D., Montori, V., Akl, E., Bryant, D., Alonso Coello, P., Alonso, J., Worster, A., Upadhye, S., Jaeschke, R., Schünemann, H.J., Permanyer-Miralda, G., Pacheco-Huergo, V., Domingo-Salvany, A., Wu, P., Mills, E.J. and Guyatt, G.H. (2007a). Problems with use of composite endpoints in cardiovascular trials: Systematic review of randomized controlled trials. British Medical Journal 334:786–792.
   PubMed Web of Science ®Google Scholar
• Ferreira-González, I., Permanyer-Miralda, G., Busse, J., Bryant, D., Montori, V., Alonso-Coello, P., Walter, S., Guyatt, G. (2007b). Methodological discussions for using and interpreting composite endpoints are limited, but still identify major concerns. Journal of Clinical Epidemiology 60:651–657.
   PubMed Web of Science ®Google Scholar
• Freemantle, N., Calvert, M., Wood, J., Eastaugh, J., Griffin, C. (2003). Composite outcomes in randomized trials. Greater precision but with greater uncertainty? Journal of the American Medical Association 289:2554–2559.
   PubMed Web of Science ®Google Scholar
• Gómez, G. (2011). Some theoretical thoughts when using a composite endpoint to prove the efficacy of a treatment. In Conesa, D., Forte, A., López-Quílez, A., Muñoz, F., Eds., Proceedings of the 26th International Workshop on Statistical Modelling, pp. 14–21. International Workshop on Statistical Modelling, Valencia. http://hdl.handle.net/2117/22571.
   Google Scholar
• Gómez, G., Gómez-Mateu, M. (2014). The asymptotic relative efficiency and the ratio of sample sizes when testing two different null hypotheses. SORT 38:73–88.
   Web of Science ®Google Scholar
• Gómez, G., Lagakos, S. (2013). Statistical considerations when using a composite endpoint for comparing treatment groups. Statistics in Medicine 32:719–738.
   PubMed Web of Science ®Google Scholar
• Gómez, G., Gómez-Mateu, M., Dafni, U. (2014). Informed choice of composite endpoints in cardiovascular trials. Circulation: Cardiovascular Quality and Outcomes 7:170–178.
   PubMed Web of Science ®Google Scholar
• Hofert, M., Maechler, M. (2011). Nested Archimedean copulas meet R: The nacopula pakage. Journal of Statistical Software 39(9):1–20.
   PubMed Web of Science ®Google Scholar
• Hofert, M., Kojadinovic, I., Maechler, M., Yan, J. (2014). Copula: Multivariate dependence with copulas. R Package Version 0.999-8.
   Google Scholar
• Huque, M. F., Alosh, M., Bhore, R. (2011). Addressing multiplicity issues of a composite endpoint and its components in clinical trials. Journal of Biopharmaceutical Statistics 21:610–634.
   PubMed Web of Science ®Google Scholar
• Joe, H. (1997). Multivariate Models and Multivariate Dependence Concepts. Monographs on Statistics and Applied Probability. London: Chapman and Hall.
   Google Scholar
• Kojadinovic, I., Yan, J. (2010). Modeling multivariate distributions with continuous margins using the copula R package. Journal of Statistical Software 34(9):1–20.
   Web of Science ®Google Scholar
• Lin, L. I. (1989). A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255–268.
   PubMed Web of Science ®Google Scholar
• Lin, L. I. (2000). A note on the concordance correlation coefficient. Biometrics 56:324–325.
   Google Scholar
• Meinert, C. L. (2012). Clinical Trials Dictionary. Hoboken, NJ: John Wiley and Sons, Inc.
   Google Scholar
• Montori, V., Permanyer-Miralda, G., Ferreira-González, I., Busse, J., Pachecho-Huergo, V., Bryant, D., Alonso, J., Akl, E., Domingo-Salvany, A., Mills, E., Wu, P., Schunemann, H., Jaeschke, R., Guyatt, G. (2007). Validity of composite endpoints in clinical trials. British Medical Journal 330:594–596.
   Web of Science ®Google Scholar
• Nelsen, R. B. (1999). An Introduction to Copulas. Lecture Notes in Statistics. New York, NY: Springer-Verlag.
   Google Scholar
• Packer, M., Coats, A., Fowler, M., Katus, H., Krum, H., Mohacsi, P., Rouleau, J., Tendera, M., Castaigne, A., Roecker, E., Schultz, M., DeMets, D. (2001). Effect of carvedilol on survival in severe chronic heart failure. The New England Journal of Medicine 344:1651–1658.
   PubMed Web of Science ®Google Scholar
• Song, R., Cook, T. D., Kosorok, M. R. (2008). What we want versus what we can get: A closer look at failure time endpoints for cardiovascular studies. Journal of Biopharmaceutical Statistics 18:370–381.
   PubMed Web of Science ®Google Scholar
• Tardif, J., McMurray, J., Klug, E., Small, R., Schumi, J., Cooper, J., Scott, R., Lewis, E., L’Allier, P., and Pfeffer, MA. for the Aggressive Reduction of Inflammation Stops Events (ARISE) Trial Investigators. (2008). Effects of succinobucol (AGI-1067) after an acute coronary syndrome: A randomised, double-blind, placebo-controlled trial. The Lancet 371:1761–1768.
   PubMed Web of Science ®Google Scholar
• Trivedi, P., Zimmer, D. (2007). Copula Modelling: An Introduction for Practitioners. Hanover, MA: Foundation and Trends in Econometrics.
   Google Scholar
• Yan, J. (2007). Enjoy the joy of copulas: With a package copula. Journal of Statistical Software 21(4): 1–21.
   Web of Science ®Google Scholar